From Oct 11 to 13, 2019, the 2019 ISPE-CCFDIE China Conference, jointly organized by China Center for Food and Drug International Exchange (CCFDIE), NMPA Center for Food and Drug Inspection and the International Society for Pharmaceutical Engineering (ISPE), was successfully held in Nanchang. 

Since its inception in 2007, ISPE-CCFDIE China Conference has been successfully held for 13 consecutive years with various forms and rich contents, and ever-growing authority and influence. The conference has become an important platform for publicizing China's drug regulatory laws and regulations, understanding the latest regulatory trends overseas, sharing the latest pharmaceutical technologies, and transmitting information. It also plays a positive role in promoting the development of China's pharmaceutical industry, and ensuring the quality and safety of pharmaceutical production. 

In 2019, ISPE-CCFDIE China Conference consisted of six special sessions, namely, the Pharmaceutical Production and Quality Management Exchange Conference, the General Assembly, the National Drug Inspection Special Work Conference, the CFDI (Center for Food and Drug Inspection) Special Session, the ICH Q5 Special Session, and the ICH Q6 Special Session; and six Technical Subconferences. The conference invited more than 60 experts and scholars from the Chinese and foreign drug regulatory authorities, industry associations, and pharmaceutical companies to exchange and discuss hot topics such as the new requirements for production and quality management as per the newly revisedDrug Administration Law, drug standards, drug inspection in the new era, quality consistency evaluation of generic drugs, pharmaceutical production and engineering, biopharmaceutical production process, ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) biotechnology product quality (Q5) guide, and ICH quality standard (Q6) guide, etc. More than 700 delegates attended the conference.